Circulating Tumor Cells Measurements in Hepatocellular Carcinoma
Liver cancer is the fifth most common cancer in men and the seventh in women. During the past 20 years, the incidence of HCC has tripled while the 5-year survival rate has remained below 12%. The presence of circulating tumor cells (CTC) reflects the aggressiveness nature of a tumor. Many attempts h...
Saved in:
Main Author: | Franck Chiappini |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2012/684802 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma
by: Ibrahim Büdeyri, et al.
Published: (2024-12-01) -
Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma
by: María L. Espejo-Cruz, et al.
Published: (2025-01-01) -
Assessing the Causal Effect of Circulating Protein‐To‐Protein Ratio on the Risk of Morbidity of Hepatocellular Carcinoma
by: Qiuyuan Yue, et al.
Published: (2025-01-01) -
Circulating tumor DNA as a therapeutic approach for HPV (+) oropharyngeal squamous cell carcinoma
by: Raghul Murugan
Published: (2024-09-01) -
Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma
by: Zeynep Kacar, et al.
Published: (2024-03-01)